Atlas Trials

Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302

Clinical trial NCT07762638 · AVAILABLE

Trial details

NCT number
NCT07762638
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Fabry Disease

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.